Overview

Safety and Efficacy of an Injectable Fluocinolone Acetonide Intravitreal Insert

Status:
Completed
Trial end date:
2018-03-26
Target enrollment:
Participant gender:
Summary
A study to evaluate the safety and efficacy of an FAI insert for the management of subjects with non-infectious uveitis affecting the posterior segment of the eye.
Phase:
Phase 3
Details
Lead Sponsor:
EyePoint Pharmaceuticals, Inc.
pSivida Corp.
Treatments:
Fluocinolone Acetonide